 | • レポートコード：QAF27886 • 出版社/出版日：QYResearch / 2021年4月13日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、144ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界の硬化治療市場について種類別（洗剤、浸透圧剤、化学刺激物）、用途別（静脈疾患、消化管出血、気管支胸膜瘻、嚢胞性疾患）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・硬化治療市場の概要 ・世界の主要地域別硬化治療市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界の硬化治療市場規模2016-2021：種類別（洗剤、浸透圧剤、化学刺激物） ・世界の硬化治療市場予測2012-2027：種類別（洗剤、浸透圧剤、化学刺激物） ・世界の硬化治療市場規模2016-2021：用途別（静脈疾患、消化管出血、気管支胸膜瘻、嚢胞性疾患） ・世界の硬化治療市場予測2012-2027：用途別（静脈疾患、消化管出血、気管支胸膜瘻、嚢胞性疾患） ・硬化治療のアメリカ市場規模と予測2016-2021 ・硬化治療のヨーロッパ市場規模と予測2016-2021 ・硬化治療の中国市場規模と予測2016-2021 ・硬化治療の日本市場規模と予測2016-2021 ・硬化治療の東南アジア市場規模と予測2016-2021 ・硬化治療のインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （BTG、Kreussler、LGM Pharma、Troikaa、Changan Tianyu group、Bioniche Pharma Group Ltd、Omega Pharmaceuticals、Angiodynamics、ENDO-FLEX、MTW ENDOSKOPIE、Cook Medical） ・硬化治療の製造コスト分析 ・販売チャネル、流通業者、顧客 ・硬化治療の市場動向・機会・課題 ・調査の結論 |
Sclerotherapy is a procedure used to treat blood vessels or blood vessel malformations (vascular malformations) and also those of the lymphatic system. A medicine is injected into the vessels, which makes them shrink. It is used for children and young adults with vascular or lymphatic malformations. In adults, sclerotherapy is often used to treat spider veins, smaller varicose veins, and hemorrhoids.
Now more respected hospital minimally invasive surgical procedure, Sclerotherapy Treatment is relatively old. And there is a lot of shortcomings hardener. For example, it will be very painful in the course of treatment. But also produce pigmentation, or inflammation, swelling and other consequences, so I do not recommend using this method for the treatment of vascular malformations
Average industry gross margin is about 63.95%. However, due to the emergence of new treatments is not recommended investment.
Market Analysis and Insights: Global Sclerotherapy Market
The global Sclerotherapy market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.
Global Sclerotherapy Scope and Market Size
The global Sclerotherapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Sclerotherapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Detergents
Osmotic Agents
Chemical Irritants
Segment by Application
Venous Disease
Gastrointestinal Bleeding
Bronchopleural Fistula
Cystic Disease
The Sclerotherapy market is analysed and market size information is provided by regions (countries). Segment by Application, the Sclerotherapy market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
BTG
Kreussler
LGM Pharma
Troikaa
Changan Tianyu group
Bioniche Pharma Group Ltd
Omega Pharmaceuticals
Angiodynamics
ENDO-FLEX
MTW ENDOSKOPIE
Cook Medical
1 Sclerotherapy Market Overview
1.1 Sclerotherapy Product Scope
1.2 Sclerotherapy Segment by Type
1.2.1 Global Sclerotherapy Sales by Type (2016 & 2021 & 2027)
1.2.2 Detergents
1.2.3 Osmotic Agents
1.2.4 Chemical Irritants
1.3 Sclerotherapy Segment by Application
1.3.1 Global Sclerotherapy Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Venous Disease
1.3.3 Gastrointestinal Bleeding
1.3.4 Bronchopleural Fistula
1.3.5 Cystic Disease
1.4 Sclerotherapy Market Estimates and Forecasts (2016-2027)
1.4.1 Global Sclerotherapy Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Sclerotherapy Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Sclerotherapy Price Trends (2016-2027)
2 Sclerotherapy Estimates and Forecasts by Region
2.1 Global Sclerotherapy Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Sclerotherapy Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Sclerotherapy Sales Market Share by Region (2016-2021)
2.2.2 Global Sclerotherapy Revenue Market Share by Region (2016-2021)
2.3 Global Sclerotherapy Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Sclerotherapy Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Sclerotherapy Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Sclerotherapy Estimates and Projections (2016-2027)
2.4.2 Europe Sclerotherapy Estimates and Projections (2016-2027)
2.4.3 China Sclerotherapy Estimates and Projections (2016-2027)
2.4.4 Japan Sclerotherapy Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Sclerotherapy Estimates and Projections (2016-2027)
2.4.6 India Sclerotherapy Estimates and Projections (2016-2027)
3 Global Sclerotherapy Competition Landscape by Players
3.1 Global Top Sclerotherapy Players by Sales (2016-2021)
3.2 Global Top Sclerotherapy Players by Revenue (2016-2021)
3.3 Global Sclerotherapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Sclerotherapy as of 2020)
3.4 Global Sclerotherapy Average Price by Company (2016-2021)
3.5 Manufacturers Sclerotherapy Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Sclerotherapy Market Size by Type
4.1 Global Sclerotherapy Historic Market Review by Type (2016-2021)
4.1.1 Global Sclerotherapy Sales Market Share by Type (2016-2021)
4.1.2 Global Sclerotherapy Revenue Market Share by Type (2016-2021)
4.1.3 Global Sclerotherapy Price by Type (2016-2021)
4.2 Global Sclerotherapy Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Sclerotherapy Sales Forecast by Type (2022-2027)
4.2.2 Global Sclerotherapy Revenue Forecast by Type (2022-2027)
4.2.3 Global Sclerotherapy Price Forecast by Type (2022-2027)
5 Global Sclerotherapy Market Size by Application
5.1 Global Sclerotherapy Historic Market Review by Application (2016-2021)
5.1.1 Global Sclerotherapy Sales Market Share by Application (2016-2021)
5.1.2 Global Sclerotherapy Revenue Market Share by Application (2016-2021)
5.1.3 Global Sclerotherapy Price by Application (2016-2021)
5.2 Global Sclerotherapy Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Sclerotherapy Sales Forecast by Application (2022-2027)
5.2.2 Global Sclerotherapy Revenue Forecast by Application (2022-2027)
5.2.3 Global Sclerotherapy Price Forecast by Application (2022-2027)
6 North America Sclerotherapy Market Facts & Figures
6.1 North America Sclerotherapy Sales by Company
6.1.1 North America Sclerotherapy Sales by Company (2016-2021)
6.1.2 North America Sclerotherapy Revenue by Company (2016-2021)
6.2 North America Sclerotherapy Sales Breakdown by Type
6.2.1 North America Sclerotherapy Sales Breakdown by Type (2016-2021)
6.2.2 North America Sclerotherapy Sales Breakdown by Type (2022-2027)
6.3 North America Sclerotherapy Sales Breakdown by Application
6.3.1 North America Sclerotherapy Sales Breakdown by Application (2016-2021)
6.3.2 North America Sclerotherapy Sales Breakdown by Application (2022-2027)
7 Europe Sclerotherapy Market Facts & Figures
7.1 Europe Sclerotherapy Sales by Company
7.1.1 Europe Sclerotherapy Sales by Company (2016-2021)
7.1.2 Europe Sclerotherapy Revenue by Company (2016-2021)
7.2 Europe Sclerotherapy Sales Breakdown by Type
7.2.1 Europe Sclerotherapy Sales Breakdown by Type (2016-2021)
7.2.2 Europe Sclerotherapy Sales Breakdown by Type (2022-2027)
7.3 Europe Sclerotherapy Sales Breakdown by Application
7.3.1 Europe 144 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 144 Sales Breakdown by Application (2022-2027)
8 China Sclerotherapy Market Facts & Figures
8.1 China Sclerotherapy Sales by Company
8.1.1 China Sclerotherapy Sales by Company (2016-2021)
8.1.2 China Sclerotherapy Revenue by Company (2016-2021)
8.2 China Sclerotherapy Sales Breakdown by Type
8.2.1 China Sclerotherapy Sales Breakdown by Type (2016-2021)
8.2.2 China Sclerotherapy Sales Breakdown by Type (2022-2027)
8.3 China Sclerotherapy Sales Breakdown by Application
8.3.1 China 314 Sales Breakdown by Application (2016-2021)
8.3.2 China 314 Sales Breakdown by Application (2022-2027)
9 Japan Sclerotherapy Market Facts & Figures
9.1 Japan Sclerotherapy Sales by Company
9.1.1 Japan Sclerotherapy Sales by Company (2016-2021)
9.1.2 Japan Sclerotherapy Revenue by Company (2016-2021)
9.2 Japan Sclerotherapy Sales Breakdown by Type
9.2.1 Japan Sclerotherapy Sales Breakdown by Type (2016-2021)
9.2.2 Japan Sclerotherapy Sales Breakdown by Type (2022-2027)
9.3 Japan Sclerotherapy Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Sclerotherapy Market Facts & Figures
10.1 Southeast Asia Sclerotherapy Sales by Company
10.1.1 Southeast Asia Sclerotherapy Sales by Company (2016-2021)
10.1.2 Southeast Asia Sclerotherapy Revenue by Company (2016-2021)
10.2 Southeast Asia Sclerotherapy Sales Breakdown by Type
10.2.1 Southeast Asia Sclerotherapy Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Sclerotherapy Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Sclerotherapy Sales Breakdown by Application
10.3.1 Southeast Asia K Pcs Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Pcs Sales Breakdown by Application (2022-2027)
11 India Sclerotherapy Market Facts & Figures
11.1 India Sclerotherapy Sales by Company
11.1.1 India Sclerotherapy Sales by Company (2016-2021)
11.1.2 India Sclerotherapy Revenue by Company (2016-2021)
11.2 India Sclerotherapy Sales Breakdown by Type
11.2.1 India Sclerotherapy Sales Breakdown by Type (2016-2021)
11.2.2 India Sclerotherapy Sales Breakdown by Type (2022-2027)
11.3 India Sclerotherapy Sales Breakdown by Application
11.3.1 India Sclerotherapy Sales Breakdown by Application (2016-2021)
11.3.2 India Sclerotherapy Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Sclerotherapy Business
12.1 BTG
12.1.1 BTG Corporation Information
12.1.2 BTG Business Overview
12.1.3 BTG Sclerotherapy Sales, Revenue and Gross Margin (2016-2021)
12.1.4 BTG Sclerotherapy Products Offered
12.1.5 BTG Recent Development
12.2 Kreussler
12.2.1 Kreussler Corporation Information
12.2.2 Kreussler Business Overview
12.2.3 Kreussler Sclerotherapy Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Kreussler Sclerotherapy Products Offered
12.2.5 Kreussler Recent Development
12.3 LGM Pharma
12.3.1 LGM Pharma Corporation Information
12.3.2 LGM Pharma Business Overview
12.3.3 LGM Pharma Sclerotherapy Sales, Revenue and Gross Margin (2016-2021)
12.3.4 LGM Pharma Sclerotherapy Products Offered
12.3.5 LGM Pharma Recent Development
12.4 Troikaa
12.4.1 Troikaa Corporation Information
12.4.2 Troikaa Business Overview
12.4.3 Troikaa Sclerotherapy Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Troikaa Sclerotherapy Products Offered
12.4.5 Troikaa Recent Development
12.5 Changan Tianyu group
12.5.1 Changan Tianyu group Corporation Information
12.5.2 Changan Tianyu group Business Overview
12.5.3 Changan Tianyu group Sclerotherapy Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Changan Tianyu group Sclerotherapy Products Offered
12.5.5 Changan Tianyu group Recent Development
12.6 Bioniche Pharma Group Ltd
12.6.1 Bioniche Pharma Group Ltd Corporation Information
12.6.2 Bioniche Pharma Group Ltd Business Overview
12.6.3 Bioniche Pharma Group Ltd Sclerotherapy Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Bioniche Pharma Group Ltd Sclerotherapy Products Offered
12.6.5 Bioniche Pharma Group Ltd Recent Development
12.7 Omega Pharmaceuticals
12.7.1 Omega Pharmaceuticals Corporation Information
12.7.2 Omega Pharmaceuticals Business Overview
12.7.3 Omega Pharmaceuticals Sclerotherapy Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Omega Pharmaceuticals Sclerotherapy Products Offered
12.7.5 Omega Pharmaceuticals Recent Development
12.8 Angiodynamics
12.8.1 Angiodynamics Corporation Information
12.8.2 Angiodynamics Business Overview
12.8.3 Angiodynamics Sclerotherapy Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Angiodynamics Sclerotherapy Products Offered
12.8.5 Angiodynamics Recent Development
12.9 ENDO-FLEX
12.9.1 ENDO-FLEX Corporation Information
12.9.2 ENDO-FLEX Business Overview
12.9.3 ENDO-FLEX Sclerotherapy Sales, Revenue and Gross Margin (2016-2021)
12.9.4 ENDO-FLEX Sclerotherapy Products Offered
12.9.5 ENDO-FLEX Recent Development
12.10 MTW ENDOSKOPIE
12.10.1 MTW ENDOSKOPIE Corporation Information
12.10.2 MTW ENDOSKOPIE Business Overview
12.10.3 MTW ENDOSKOPIE Sclerotherapy Sales, Revenue and Gross Margin (2016-2021)
12.10.4 MTW ENDOSKOPIE Sclerotherapy Products Offered
12.10.5 MTW ENDOSKOPIE Recent Development
12.11 Cook Medical
12.11.1 Cook Medical Corporation Information
12.11.2 Cook Medical Business Overview
12.11.3 Cook Medical Sclerotherapy Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Cook Medical Sclerotherapy Products Offered
12.11.5 Cook Medical Recent Development
13 Sclerotherapy Manufacturing Cost Analysis
13.1 Sclerotherapy Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Sclerotherapy
13.4 Sclerotherapy Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Sclerotherapy Distributors List
14.3 Sclerotherapy Customers
15 Market Dynamics
15.1 Sclerotherapy Market Trends
15.2 Sclerotherapy Drivers
15.3 Sclerotherapy Market Challenges
15.4 Sclerotherapy Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Sclerotherapy Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Sclerotherapy Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Sclerotherapy Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Sclerotherapy Sales (K Pcs) by Region (2016-2021)
Table 5. Global Sclerotherapy Sales Market Share by Region (2016-2021)
Table 6. Global Sclerotherapy Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Sclerotherapy Revenue Share by Region (2016-2021)
Table 8. Global Sclerotherapy Sales (K Pcs) Forecast by Region (2022-2027)
Table 9. Global Sclerotherapy Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Sclerotherapy Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Sclerotherapy Revenue Share Forecast by Region (2022-2027)
Table 12. Global Sclerotherapy Sales (K Pcs) of Key Companies (2016-2021)
Table 13. Global Sclerotherapy Sales Share by Company (2016-2021)
Table 14. Global Sclerotherapy Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Sclerotherapy Revenue Share by Company (2016-2021)
Table 16. Global Sclerotherapy by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sclerotherapy as of 2020)
Table 17. Global Sclerotherapy Average Price (USD/Pcs) of Key Company (2016-2021)
Table 18. Manufacturers Sclerotherapy Manufacturing Sites and Area Served
Table 19. Manufacturers Sclerotherapy Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Sclerotherapy Sales (K Pcs) by Type (2016-2021)
Table 22. Global Sclerotherapy Sales Share by Type (2016-2021)
Table 23. Global Sclerotherapy Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Sclerotherapy Price (USD/Pcs) by Type (2016-2021)
Table 25. Global Sclerotherapy Sales Share by Type (2022-2027)
Table 26. Global Sclerotherapy Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Sclerotherapy Revenue Share by Type (2022-2027)
Table 28. Global Sclerotherapy Price (USD/Pcs) by Type (2022-2027)
Table 29. Global Sclerotherapy Sales (K Pcs) by Application (2016-2021)
Table 30. Global Sclerotherapy Sales Share by Application (2016-2021)
Table 31. Global Sclerotherapy Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Sclerotherapy Price (USD/Pcs) by Application (2016-2021)
Table 33. Global Sclerotherapy Sales (K Pcs) by Application (2022-2027)
Table 34. Global Sclerotherapy Sales Share by Application (2022-2027)
Table 35. Global Sclerotherapy Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Sclerotherapy Revenue Share by Application (2022-2027)
Table 37. Global Sclerotherapy Price (USD/Pcs) by Application (2022-2027)
Table 38. North America Sclerotherapy Sales (K Pcs) by Company (2016-2021)
Table 39. North America Sclerotherapy Sales Market Share by Company (2016-2021)
Table 40. North America Sclerotherapy Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Sclerotherapy Revenue Market Share by Company (2016-2021)
Table 42. North America Sclerotherapy Sales by Type (2016-2021) & (K Pcs)
Table 43. North America Sclerotherapy Sales Market Share by Type (2016-2021)
Table 44. North America Sclerotherapy Sales by Type (2022-2027) & (K Pcs)
Table 45. North America Sclerotherapy Sales Market Share by Type (2022-2027)
Table 46. North America Sclerotherapy Sales by Application (2016-2021) & (K Pcs)
Table 47. North America Sclerotherapy Sales Market Share by Application (2016-2021)
Table 48. North America Sclerotherapy Sales by Application (2022-2027) & (K Pcs)
Table 49. North America Sclerotherapy Sales Market Share by Application (2022-2027)
Table 50. Europe Sclerotherapy Sales (K Pcs) by Company (2016-2021)
Table 51. Europe Sclerotherapy Sales Market Share by Company (2016-2021)
Table 52. Europe Sclerotherapy Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Sclerotherapy Revenue Market Share by Company (2016-2021)
Table 54. Europe Sclerotherapy Sales by Type (2016-2021) & (K Pcs)
Table 55. Europe Sclerotherapy Sales Market Share by Type (2016-2021)
Table 56. Europe Sclerotherapy Sales by Type (2022-2027) & (K Pcs)
Table 57. Europe Sclerotherapy Sales Market Share by Type (2022-2027)
Table 58. Europe Sclerotherapy Sales by Application (2016-2021) & (K Pcs)
Table 59. Europe Sclerotherapy Sales Market Share by Application (2016-2021)
Table 60. Europe Sclerotherapy Sales by Application (2022-2027) & (K Pcs)
Table 61. Europe Sclerotherapy Sales Market Share by Application (2022-2027)
Table 62. China Sclerotherapy Sales (K Pcs) by Company (2016-2021)
Table 63. China Sclerotherapy Sales Market Share by Company (2016-2021)
Table 64. China Sclerotherapy Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Sclerotherapy Revenue Market Share by Company (2016-2021)
Table 66. China Sclerotherapy Sales by Type (2016-2021) & (K Pcs)
Table 67. China Sclerotherapy Sales Market Share by Type (2016-2021)
Table 68. China Sclerotherapy Sales by Type (2022-2027) & (K Pcs)
Table 69. China Sclerotherapy Sales Market Share by Type (2022-2027)
Table 70. China Sclerotherapy Sales by Application (2016-2021) & (K Pcs)
Table 71. China Sclerotherapy Sales Market Share by Application (2016-2021)
Table 72. China Sclerotherapy Sales by Application (2022-2027) & (K Pcs)
Table 73. China Sclerotherapy Sales Market Share by Application (2022-2027)
Table 74. Japan Sclerotherapy Sales (K Pcs) by Company (2016-2021)
Table 75. Japan Sclerotherapy Sales Market Share by Company (2016-2021)
Table 76. Japan Sclerotherapy Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Sclerotherapy Revenue Market Share by Company (2016-2021)
Table 78. Japan Sclerotherapy Sales by Type (2016-2021) & (K Pcs)
Table 79. Japan Sclerotherapy Sales Market Share by Type (2016-2021)
Table 80. Japan Sclerotherapy Sales by Type (2022-2027) & (K Pcs)
Table 81. Japan Sclerotherapy Sales Market Share by Type (2022-2027)
Table 82. Japan Sclerotherapy Sales by Application (2016-2021) & (K Pcs)
Table 83. Japan Sclerotherapy Sales Market Share by Application (2016-2021)
Table 84. Japan Sclerotherapy Sales by Application (2022-2027) & (K Pcs)
Table 85. Japan Sclerotherapy Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Sclerotherapy Sales (K Pcs) by Company (2016-2021)
Table 87. Southeast Asia Sclerotherapy Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Sclerotherapy Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Sclerotherapy Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Sclerotherapy Sales by Type (2016-2021) & (K Pcs)
Table 91. Southeast Asia Sclerotherapy Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Sclerotherapy Sales by Type (2022-2027) & (K Pcs)
Table 93. Southeast Asia Sclerotherapy Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Sclerotherapy Sales by Application (2016-2021) & (K Pcs)
Table 95. Southeast Asia Sclerotherapy Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Sclerotherapy Sales by Application (2022-2027) & (K Pcs)
Table 97. Southeast Asia Sclerotherapy Sales Market Share by Application (2022-2027)
Table 98. India Sclerotherapy Sales (K Pcs) by Company (2016-2021)
Table 99. India Sclerotherapy Sales Market Share by Company (2016-2021)
Table 100. India Sclerotherapy Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Sclerotherapy Revenue Market Share by Company (2016-2021)
Table 102. India Sclerotherapy Sales by Type (2016-2021) & (K Pcs)
Table 103. India Sclerotherapy Sales Market Share by Type (2016-2021)
Table 104. India Sclerotherapy Sales by Type (2022-2027) & (K Pcs)
Table 105. India Sclerotherapy Sales Market Share by Type (2022-2027)
Table 106. India Sclerotherapy Sales by Application (2016-2021) & (K Pcs)
Table 107. India Sclerotherapy Sales Market Share by Application (2016-2021)
Table 108. India Sclerotherapy Sales by Application (2022-2027) & (K Pcs)
Table 109. India Sclerotherapy Sales Market Share by Application (2022-2027)
Table 110. BTG Corporation Information
Table 111. BTG Description and Business Overview
Table 112. BTG Sclerotherapy Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 113. BTG Sclerotherapy Product
Table 114. BTG Recent Development
Table 115. Kreussler Corporation Information
Table 116. Kreussler Description and Business Overview
Table 117. Kreussler Sclerotherapy Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 118. Kreussler Sclerotherapy Product
Table 119. Kreussler Recent Development
Table 120. LGM Pharma Corporation Information
Table 121. LGM Pharma Description and Business Overview
Table 122. LGM Pharma Sclerotherapy Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 123. LGM Pharma Sclerotherapy Product
Table 124. LGM Pharma Recent Development
Table 125. Troikaa Corporation Information
Table 126. Troikaa Description and Business Overview
Table 127. Troikaa Sclerotherapy Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 128. Troikaa Sclerotherapy Product
Table 129. Troikaa Recent Development
Table 130. Changan Tianyu group Corporation Information
Table 131. Changan Tianyu group Description and Business Overview
Table 132. Changan Tianyu group Sclerotherapy Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 133. Changan Tianyu group Sclerotherapy Product
Table 134. Changan Tianyu group Recent Development
Table 135. Bioniche Pharma Group Ltd Corporation Information
Table 136. Bioniche Pharma Group Ltd Description and Business Overview
Table 137. Bioniche Pharma Group Ltd Sclerotherapy Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 138. Bioniche Pharma Group Ltd Sclerotherapy Product
Table 139. Bioniche Pharma Group Ltd Recent Development
Table 140. Omega Pharmaceuticals Corporation Information
Table 141. Omega Pharmaceuticals Description and Business Overview
Table 142. Omega Pharmaceuticals Sclerotherapy Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 143. Omega Pharmaceuticals Sclerotherapy Product
Table 144. Omega Pharmaceuticals Recent Development
Table 145. Angiodynamics Corporation Information
Table 146. Angiodynamics Sclerotherapy Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 147. Angiodynamics Description and Business Overview
Table 148. Angiodynamics Sclerotherapy Product
Table 149. Angiodynamics Recent Development
Table 150. ENDO-FLEX Corporation Information
Table 151. ENDO-FLEX Sclerotherapy Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 152. ENDO-FLEX Description and Business Overview
Table 153. ENDO-FLEX Sclerotherapy Product
Table 154. ENDO-FLEX Recent Development
Table 155. MTW ENDOSKOPIE Corporation Information
Table 156. MTW ENDOSKOPIE Description and Business Overview
Table 157. MTW ENDOSKOPIE Sclerotherapy Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 158. MTW ENDOSKOPIE Sclerotherapy Product
Table 159. MTW ENDOSKOPIE Recent Development
Table 160. Cook Medical Corporation Information
Table 161. Cook Medical Description and Business Overview
Table 162. Cook Medical Sclerotherapy Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 163. Cook Medical Sclerotherapy Product
Table 164. Cook Medical Recent Development
Table 165. Production Base and Market Concentration Rate of Raw Material
Table 166. Key Suppliers of Raw Materials
Table 167. Sclerotherapy Distributors List
Table 168. Sclerotherapy Customers List
Table 169. Sclerotherapy Market Trends
Table 170. Sclerotherapy Market Drivers
Table 171. Sclerotherapy Market Challenges
Table 172. Sclerotherapy Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Sclerotherapy Product Picture
Figure 2. Global Sclerotherapy Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Sclerotherapy Sales Market Share by Application in 2021 & 2027
Figure 6. Venous Disease Examples
Figure 7. Gastrointestinal Bleeding Examples
Figure 8. Bronchopleural Fistula Examples
Figure 9. Cystic Disease Examples
Figure 10. Global Sclerotherapy Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Sclerotherapy Sales Growth Rate (2016-2027) & (US$ Million)
Figure 12. Global Sclerotherapy Sales (K Pcs) Growth Rate (2016-2027)
Figure 13. Global Sclerotherapy Price Trends Growth Rate (2016-2027) (USD/Pcs)
Figure 14. Global Sclerotherapy Revenue Market Share by Region: 2016 VS 2021
Figure 15. Global Sclerotherapy Revenue Market Share by Region: 2021 VS 2027
Figure 16. North America Sclerotherapy Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. North America Sclerotherapy Sales (K Pcs) Growth Rate (2016-2027)
Figure 18. Europe Sclerotherapy Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. Europe Sclerotherapy Sales (Million USD) Growth Rate (2016-2027)
Figure 20. China Sclerotherapy Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. China Sclerotherapy Sales (Million USD) and Growth Rate (2016-2027)
Figure 22. Japan Sclerotherapy Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Japan Sclerotherapy Sales (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Sclerotherapy Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. Southeast Asia Sclerotherapy Sales (Million USD) Growth Rate (2016-2027)
Figure 26. India Sclerotherapy Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. India Sclerotherapy Sales (Million USD) Growth Rate (2016-2027)
Figure 28. Global 5 Largest Sclerotherapy Players Market Share by Revenue in Sclerotherapy: 2016 & 2020
Figure 29. Sclerotherapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 30. Global Sclerotherapy Revenue Share by Type (2016-2021)
Figure 31. Global Sclerotherapy Revenue Growth Rate by Type in 2016 & 2020
Figure 32. Global Sclerotherapy Revenue Share by Application (2016-2021)
Figure 33. Global Sclerotherapy Revenue Growth Rate by Application in 2016 & 2020
Figure 34. North America Sclerotherapy Sales Market Share by Type in 2020
Figure 35. North America Sclerotherapy Sales Market Share by Application in 2020
Figure 36. Europe Sclerotherapy Sales Market Share by Type in 2020
Figure 37. Europe Sclerotherapy Sales Market Share by Application in 2020
Figure 38. China Sclerotherapy Sales Market Share by Type in 2020
Figure 39. China Sclerotherapy Sales Market Share by Application in 2020
Figure 40. Japan Sclerotherapy Sales Market Share by Type in 2020
Figure 41. Japan Sclerotherapy Sales Market Share by Application in 2020
Figure 42. Southeast Asia Sclerotherapy Sales Market Share by Type in 2020
Figure 43. Southeast Asia Sclerotherapy Sales Market Share by Application in 2020
Figure 44. India Sclerotherapy Sales Market Share by Type in 2020
Figure 45. India Sclerotherapy Sales Market Share by Application in 2020
Figure 46. Key Raw Materials Price Trend
Figure 47. Manufacturing Cost Structure of Sclerotherapy
Figure 48. Manufacturing Process Analysis of Sclerotherapy
Figure 49. Sclerotherapy Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
世界の慢性静脈閉塞治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Chronic Venous Occlusions Treatment Market The global Chronic Venous Occlusions Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and hig…- 世界の後天性嚢胞性腎疾患治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Acquired Cystic Kidney Disease Treatment Drugs Market The global Acquired Cystic Kidney Disease Treatment Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accura…
- 世界の消化管出血治療市場規模・現状・予測（2021年-2027年） Gastrointestinal bleeding is also known as gastrointestinal hemorrhage. It includes all forms of bleeding of gastrointestinal tract, from the mouth to the rectum. Endoscopic hemostatic devices are the primary line of treatment for gastrointestinal bleeding. The major endoscopic hemostatic devices in…
- 世界の腎嚢胞治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Renal Cyst Treatment Market The global Renal Cyst Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report m…
- アルツハイマー病治療薬のグローバル市場2021 Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia. Alzheimer’s disease drug are widely used for Early to Moderate, Moderate to Severe stage trea…